[Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease]

Area of Science:

• Neurogastroenterology
• Pharmacology
• Parkinson's Disease Research

Context:

• Gastrointestinal (GI) motility dysfunctions are prevalent in Parkinson's disease (PD), impacting patient quality of life.
• Degeneration of the enteric nervous system is a key factor in PD-related GI symptoms.
• Impaired gastric emptying (GE) in PD patients delays L-dopa absorption, leading to motor fluctuations like wearing-off and delayed-on phenomena.

Purpose:

• To investigate the association between impaired gastric emptying (GE) and delayed plasma L-dopa concentration in Parkinson's disease (PD) patients.
• To highlight the clinical significance of GE impairment in PD-related motor fluctuations.

Summary:

• A significant correlation was observed between delayed plasma L-dopa elevation and GE impairment in PD patients (69% vs. 22%, p=0.0044).
• Serotonin 5-HT4 agonists and dopamine D2 antagonists can improve GE impairment in PD by modulating the enteric nervous system.
• Herbal medicine Rikkunshi-to and continuous intestinal L-dopa administration are also explored for managing GI symptoms and motor fluctuations in PD.

Impact:

• Findings underscore the critical role of GE in managing L-dopa therapy and motor fluctuations in PD.
• Identifies therapeutic targets and strategies, including pharmacological agents and herbal medicine, for improving GI function in PD.
• Suggests future directions in PD treatment, such as continuous intestinal L-dopa delivery, to mitigate motor fluctuations.